Managing HIV. Part 2: Phases of disease. 2.2 Early HIV-induced immune deficiency
Kelleher, A.D.; Orth, D.
Medical Journal of Australia 164(2): 107-108
1996
ISSN/ISBN: 0025-729X PMID: 8569559 Document Number: 460094
From the resolution of primary infection until the CD4 cell count falls below 500/microL, people with HIV are usually functioning at their normal capacity physically, mentally and socially. However, HIV is replicating actively within lymph nodes during this period of early immune deficiency. It is important to determine the rate of immune depletion and to assess what factors, if any, may be hastening that progression.
Document emailed within 1 workday
Related Documents
Marriott, D.; McMurchie, M. 1996: Managing HIV. Part 2: Phases of disease. 2.4 HIV and advanced immune deficiency Medical Journal of Australia 164(2): 111-112Ffrench, R.; Stewart, G.J.; Penny, R.; Levy, J.A. 1996: Managing HIV. Part 3. Mechanisms of disease. 3.2 how HIV produces immune deficiency Medical Journal of Australia 164(3): 166-171
Csanda, E.; Tárczy, M. 1987: Selegiline in the early and late phases of Parkinson's disease Journal of Neural Transmission. Supplementum 25: 105-113
McCluskey, P.J.; Hall, A.J.; Lightman, S. 1996: Managing HIV. Part 5: Treating secondary outcomes. 5.11 HIV and eye disease Medical Journal of Australia 164(8): 484-486
Frankum, B.S.; Savdie, E. 1996: Managing HIV. Part 5: Treating secondary outcomes. 5.10 HIV and renal disease Medical Journal of Australia 164(8): 483
Carr, A.; Garsia, R. 1996: Managing HIV. Part 3: Mechanisms of disease. 3.5 how HIV leads to hypersensitivity reactions Medical Journal of Australia 164(4): 227-229
Wong, D.; Shumack, S. 1996: Managing HIV. Part 5: Treating secondary outcomes. 5.1 HIV and skin disease Medical Journal of Australia 164(6): 352-356
Weber, G.; Fabbrini, P.; Resi, L. 1973: Ultrastructural aspects of the rabbit aortic endothelial surface in the early phases of experimental cholesterol-induced atherogenesis, under the influence of Tween 80 and methylprednisolone, respectively Bollettino della Societa Italiana di Biologia Sperimentale 49(12): 748-750
Quertermous, J.; Bernardi, J.Michael.; Malone, J.; Callen, J.P. 2011: Resident rounds. Part III. Erosive and desquamative syphilis associated with mucositis in the setting of acquired immune deficiency syndrome Journal of drugs in dermatology: JDD 10(11): 1335-1336
Sievert, W.; Shaw, D.R.; Edwards, P. 1996: Managing HIV. Part 5: Treating secondary outcomes. 5.3 HIV, gastrointestinal and hepatobiliary disease Medical Journal of Australia 164(6): 360-365
Rodgers, E. 2011: Nutritionally acquired immune deficiency syndromes (NAIDS): common but often not diagnosed early Pacific Health Dialog 17(1): 149-153
Stewart, G.J.; Irvine, S.S.; Scott, M.; Kelleher, A.D.; Marriott, D.J.; McKnight, I.; Pethebridge, A.M.; Wodak, A.; Ziegler, J. 1996: Managing HIV. Part 1: Principles. 1.2 Strategies of care in managing HIV Medical Journal of Australia 164(2): 99-104
Zolla Pazner, S.; El Sadr, W.; William, D.; Stahl, R.; Marmor, M. 1985: The use of beta 2 microglobulin in the diagnosis of acquired immune deficiency syndrome suspected acquired immune deficiency syndrome and preclinical acquired immune deficiency syndrome Selikoff, I J , A S Teirstein And S Z Hirschman (Ed ) Annals Of The New York Academy Of Sciences, Vol 437 Acquired Immune Deficiency Syndrome; Meeting, New York, N Y , Usa, Nov 14-17, 1983 Xiv+622p The New York Academy Of Sciences; New York, N Y , Usa Illus 526-529, 1984
Kammermeier-Schmidt, U.; Weiss, M.; Belohradsky, B.H. 1993: X-chromosomal recessively inherited lymphoproliferative syndrome. An analysis of EBV-induced immune deficiency Monatsschrift Kinderheilkunde: Organ der Deutschen Gesellschaft für Kinderheilkunde 141(3): 201-206
Jose, J.M.; Idiculla, J.M.; Ravindran, G.D. 2010: An autoimmune disease in an immune deficiency disorder National Medical Journal of India 23(4): 252
Vassiliadis, S.; Guilbert, L.J. 1991: Immune interferon induces early and late events in differentiation of HL-60 cells that are part of the same maturation program Experimental Hematology 19(4): 250-256
Boyko, W.J.; Schechter, M.T.; Craib, K.J.P.; Constance, P.; Nitz, R.; Fay, S.; Mcleod, A.; O'shaughnessy, M. 1986: The vancouver lymphadenopathy acquired immune deficiency syndrome study 5. antecedent behavioral clinical and laboratory findings in patients with acquired immune deficiency syndrome and human immunodeficiency virus seropositive controls Canadian Medical Association Journal 135(8): 881-887
Seed, T.M.; Meyers, S.M. 1993: Chronic radiation-induced alteration in hematopoietic repair during preclinical phases of aplastic anemia and myeloproliferative disease: assessing unscheduled DNA synthesis responses Cancer Research 53(19): 4518-4527
Weiden, P.L.; Blaese, R.M. 1971: Hemolytic anemia in agammaglobulinemic chickens: a model of "autoimmune" disease in immune deficiency Journal of Immunology 107(4): 1004-1013
Smith, H.R.; Chused, T.M.; Steinberg, A.D. 1983: The effect of the X-linked immune deficiency gene (xid) upon the y chromosome-related disease of BXSB mice Journal of Immunology 131(3): 1257-1262